Beyond the guidelines for non-invasive ventilation in acute respiratory failure: implications for practice

Lancet Respir Med. 2018 Dec;6(12):935-947. doi: 10.1016/S2213-2600(18)30388-6.

Abstract

Non-invasive ventilation is standard therapy in the management of both hypoxaemic and hypercapnic respiratory failure of various causes. The evidence base for its use and when and how it should be used has been reviewed in two recent guidelines. In this Series paper, we look beyond the guidelines to what is happening in everyday clinical practice in the real world, how patient selection can be refined to maximise the chances of a successful outcome, and emerging alternative therapies. Real-world application of non-invasive ventilation diverges from guideline recommendations, particularly with regard to patient selection and timing of initiation. To improve patient outcomes education programmes need to stress these issues and the effectiveness of non-invasive ventilation that is delivered needs to be monitored by regular audit.

Publication types

  • Review

MeSH terms

  • Humans
  • Hypoxia / therapy
  • Intubation, Intratracheal / adverse effects
  • Noninvasive Ventilation / adverse effects
  • Noninvasive Ventilation / methods*
  • Noninvasive Ventilation / mortality
  • Oxygen Inhalation Therapy / methods*
  • Patient Selection
  • Practice Guidelines as Topic
  • Pulmonary Disease, Chronic Obstructive / therapy*
  • Respiratory Distress Syndrome / therapy*
  • Respiratory Insufficiency / therapy*
  • Severity of Illness Index